Singleagent rituximab as first-line and maintenance treatment for patients with chronic lymphatic leukaemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network - Hainsworth, JD; Litchy, S; Barton, JH (J Clin Oncol, 2003)